跳至主要内容
临床试验/PACTR202102767216677
PACTR202102767216677招募中2 期

The Possible Therapeutic Role of Intravenous Lipid Emulsion in Acute Aluminium Phosphide Poisoning: A Randomized Controlled Clinical Trial

Hafsa Salah Gheat0 个研究点目标入组 62 人开始时间: 2020年7月19日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
All

入选标准

  • Patients aged = 12 years old.
  • Either gender male or female.
  • Symptomatic acute ALP poisoning.
  • Diagnosis will be made on the basis of:
  • 1. The suggestive clinical manifestations due to and following shortly after exposure to ALP.
  • 2. Reliable identification of the compound based on the container brought by patient attendants
  • 3. Biochemical detection of phosphine gas in gastric aspirate (silver nitrate test)

排除标准

  • Patients less than 12 years old.
  • Pregnant and lactating women.
  • Patients with mixed ingestion or exposure.
  • Patients with other major medical conditions (e.g. cardiovascular disease, renal or hepatic failure).
  • Patients treated for acute phosphide poisoning in any medical center before admission.
  • Patient with hyperlipidemia (serum triglyceride levels exceeds 400 mg/dL)

研究者

发起方
Hafsa Salah Gheat

相似试验